IL-23, is a cytokine mainly produced by tumor-associated myeloid cells activated by microbial products such as flagellin, promotes tumor growth and progression and development of a tumoral IL-17 response (Grivennikov et al., 2012). Here, IL17A is linked to neoplasm.